18.11.2014 • News • Perrigo • Mergers & Acquisitions (M&A) • healthcare

Perrigo to Acquire Omega Pharma for €2.48 Million

To expand its over-the-counter products portfolio, Irish consumer healthcare company Perrigo plans to acquire Belgium's Omega Pharma for €2.48 billion, excluding debt.

Perrigo, which was de-listed by CEO Coucke and private equity firm Waterland in 2011, said it would also take on €1.1 million of debt from privately held Omega.
The Belgian company sells prescription-free medicines, healthcare products and personal care items such as wart treatments and suntan lotions.

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.